J84.03
Idiopathic pulmonary hemosiderosis
Clinical Classification Guidelines
Inclusion Terms
- Essential brown induration of lung
Excludes Type 1
- acute idiopathic pulmonary hemorrhage in infants [AIPHI] (R04.81)
Code First
- underlying disease, such as:
- disorders of iron metabolism (E83.1-)
Medical Intelligence & Overview
Idiopathic pulmonary hemosiderosis (IPH) is a rare lung disorder characterized by recurrent episodes of bleeding into the lungs, leading to the accumulation of iron-rich blood, known as hemosiderin, within the lung tissue. This condition primarily affects children and young adults, and its exact cause remains unknown, which is why it's termed 'idiopathic.' The disease can result in long-term lung damage if not properly managed. The term 'brown induration' refers to the characteristic color change in lung tissue due to iron deposits from repeated bleeding episodes. Recognizing this condition is essential for prompt diagnosis and management to prevent significant respiratory complications.
Causes & Symptoms
Clinical Causes: The exact cause of idiopathic pulmonary hemosiderosis is unknown. Possible immune system involvement may trigger lung bleeding episodes. Genetic factors are suspected but not well-defined. Environmental exposures have not been conclusively linked to IPH. Secondary causes, such as autoimmune disorders or infections, are generally ruled out before diagnosing idiopathic form.
Key Symptoms: Persistent or recurrent coughing Hemoptysis (coughing up blood), which can range from mild to severe Shortness of breath, especially during exertion Fatigue and weakness Pale skin and pallor due to anemia Chest discomfort or pain In some cases, fever or signs of respiratory infection may be present
Diagnostic & Treatment
Diagnosis Path: Diagnosing idiopathic pulmonary hemosiderosis involves a combination of clinical evaluation and diagnostic tests: - **Medical history and physical examination:** Noting recurrent respiratory issues and signs of anemia. - **Chest imaging:** Chest X-rays often show diffuse infiltrates, indicating bleeding or fibrosis; High-resolution CT scans provide detailed lung images. - **Laboratory tests:** Blood tests reveal anemia and iron deficiency. - **Bronchoscopy and lung biopsy:** Direct visualization and tissue sampling can detect hemosiderin-laden macrophages ('heart failure cells') and confirm bleeding episodes. - **Exclusion of other causes:** Tests to rule out autoimmune diseases, infections, or other bleeding disorders that could cause similar symptoms.
Treatment Protocols: Treatment strategies aim to control bleeding, manage symptoms, and prevent lung damage: - **Corticosteroids:** Mainstay to reduce inflammation and lessen bleeding episodes. - **Immunosuppressive medications:** Such as azathioprine or cyclophosphamide, may be used in resistant cases. - **Supportive care:** Oxygen therapy for hypoxia, blood transfusions for severe anemia. - **Monitoring:** Regular follow-ups to assess lung function and detect disease progression. - **Addressing complications:** Managing infections or other secondary issues that may arise. - **Avoidance of known triggers:** Though causes are unknown, avoiding environmental irritants may be beneficial. It is important for individuals with this condition to receive ongoing medical care to monitor and adjust treatment as needed.
Clinical Advice & FAQs
Billing Guidance
Is J84.03 a billable ICD-10 code?
Yes, J84.03 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J84.03?
Clinical documentation must specify the nature of Idiopathic pulmonary hemosiderosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference